Search Results

There are 4457 results for: content related to: Side effects of therapy of hepatitis C and their management

  1. Telaprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 951–974, Olga M. Klibanov, Shannon H. Williams, Lisa S. Smith, Jacqueline L. Olin and Stephen B. Vickery

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.10.951

  2. Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e81–e90, S. Mauss, D. Hueppe, C. John, J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber, A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N. Dikopoulos and T. Witthoeft

    Article first published online : 16 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01372.x

  3. Current Therapies for Chronic Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 1, January 2011, Pages: 92–111, McKenzie C. Ferguson

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.1.92

  4. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Article first published online : 2 DEC 2008, DOI: 10.1002/hep.22759

  5. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  6. You have free access to this content
    Hepatitis C virus: How genetic variability affects pathobiology of disease

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue s1, January 2011, Pages: 83–95, Kazuaki Chayama and C Nelson Hayes

    Article first published online : 4 JAN 2011, DOI: 10.1111/j.1440-1746.2010.06550.x

  7. Peginterferon alfa-2a versus Peginterferon alfa-2b as Initial Treatment of Hepatitis C Virus Infection: A Cost-Utility Analysis from the Perspective of the Veterans Affairs Health Care System

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 6, June 2007, Pages: 813–824, Wei-Shi Yeh, Edward P. Armstrong, Grant H. Skrepnek and Daniel C. Malone

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.27.6.813

  8. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Article first published online : 5 OCT 2005, DOI: 10.1002/hep.20927

  9. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26880

  10. You have free access to this content
    Optimal therapy of hepatitis C

    Hepatology

    Volume 36, Issue S1, November 2002, Pages: S121–S127, Adrian M. Di Bisceglie and Jay H. Hoofnagle

    Article first published online : 10 FEB 2006, DOI: 10.1002/hep.1840360716

  11. You have free access to this content
    Optimal therapy of hepatitis C

    Hepatology

    Volume 36, Issue 5B, November 2002, Pages: s121–s127, Adrian M. Di Bisceglie and Jay H. Hoofnagle

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2002.36228

  12. You have full text access to this OnlineOpen article
    Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study

    British Journal of Clinical Pharmacology

    Volume 79, Issue 3, March 2015, Pages: 514–522, Xiao Hu, Yue Cui, Joleen White, Ying Zhu, Aaron Deykin, Ivan Nestorov and Serena Hung

    Article first published online : 20 FEB 2015, DOI: 10.1111/bcp.12521

  13. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Article first published online : 19 SEP 2007, DOI: 10.1002/hep.22017

  14. COMPARE: pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects

    British Journal of Clinical Pharmacology

    Accepted manuscript online: 8 APR 2016, Xiao Hu, Shulian Shang, Ivan Nestorov, Jawad Hasan, Ali Seddighzadeh, Katherine Dawson, Bjørn Sperling and Brian Werneburg

    DOI: 10.1111/bcp.12968

  15. The Effect of Multiple Doses of Peginterferon alfa-2b on the Steady-State Pharmacokinetics of Methadone in Patients With Chronic Hepatitis C Undergoing Methadone Maintenance Therapy

    The Journal of Clinical Pharmacology

    Volume 47, Issue 5, May 2007, Pages: 604–612, Dr Samir K. Gupta, Dr Edward Sellers, Dr Eugene Somoza, Dr Luis Angles, Dr Karen Kolz and Dr David L. Cutler

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007299760

  16. APASL Abstracts, Bali 2005

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1270–1384,

    Article first published online : 11 NOV 2005, DOI: 10.1111/j.1478-3231.2005.01182.x

  17. You have free access to this content
    Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirin

    Hepatology

    Volume 48, Issue 4, October 2008, Pages: 1033–1043, Michael W. Fried, Donald M. Jensen, Maribel Rodriguez-Torres, Lisa M. Nyberg, Adrian M. Di Bisceglie, Timothy R. Morgan, Paul J. Pockros, Amy Lin, Lisa Cupelli, Frank Duff, Ka Wang and David R. Nelson

    Article first published online : 9 JUN 2008, DOI: 10.1002/hep.22448

  18. You have free access to this content
    Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

    Hepatology

    Volume 35, Issue 4, April 2002, Pages: 930–936, Maria Buti, Francisco Sanchez-Avila, Yoav Lurie, Carlos Stalgis, Auristela Valdés, Maria Martell and Rafael Esteban

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2002.32150

  19. You have free access to this content
    A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C

    Hepatology

    Volume 34, Issue 2, August 2001, Pages: 395–403, Karen L. Lindsay, Christian Trepo, Tobias Heintges, Mitchell L. Shiffman, Stuart C. Gordon, John C. Hoefs, Eugene R. Schiff, Zachary D. Goodman, Mark Laughlin, Ruji Yao and Janice K. Albrecht

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2001.26371

  20. Patient Education and Treatment Strategies Implemented at a Pharmacist-Managed Hepatitis C Virus Clinic

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 9, September 2005, Pages: 1230–1241, Bonnie Kolor

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.9.1230